2018
DOI: 10.20945/2359-3997000000024
|View full text |Cite
|
Sign up to set email alerts
|

Effect of one time high dose “stoss therapy” of vitamin D on glucose homeostasis in high risk obese adolescents

Abstract: Our study demonstrated that using a high dose of VD2 (300,000 IU) did not have any beneficial effect on insulin sensitivity (whole body sensitivity index {WBISI}) and secretory indices (insulinogenic index {IGI}) in obese adolescents. High dose "stoss therapy" of VD2 did not appear to have any beneficial effect on glucose homeostasis on obese adolescents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 34 publications
0
10
0
Order By: Relevance
“…In the past two decades, numerous observational studies suggested vitamin D deficiency was a risk factor for obesity, T2D, insulin resistance and metabolic syndrome, while hypothesising that re-establishing vitamin D adequacy could lead to the improvement of these conditions. However, there is a lack of conclusive evidence from randomized control clinical trials to support that optimization of 25OHD levels is able to prevent these metabolic disorders (174), has beneficial effects on glucose homeostasis (175) or results in a lower incidence of cardiovascular events (176). Therefore, vitamin D supplementation with the sole purpose of promoting weight loss, decreasing the risk of obesityrelated co-morbidities or improve ongoing metabolic conditions cannot be recommended.…”
Section: Reasoningmentioning
confidence: 99%
“…In the past two decades, numerous observational studies suggested vitamin D deficiency was a risk factor for obesity, T2D, insulin resistance and metabolic syndrome, while hypothesising that re-establishing vitamin D adequacy could lead to the improvement of these conditions. However, there is a lack of conclusive evidence from randomized control clinical trials to support that optimization of 25OHD levels is able to prevent these metabolic disorders (174), has beneficial effects on glucose homeostasis (175) or results in a lower incidence of cardiovascular events (176). Therefore, vitamin D supplementation with the sole purpose of promoting weight loss, decreasing the risk of obesityrelated co-morbidities or improve ongoing metabolic conditions cannot be recommended.…”
Section: Reasoningmentioning
confidence: 99%
“…As discussed previously, there is evidence of association between low levels of vitamin D and cardiovascular risk factors in children, which may lead to cardiovascular diseases in adulthood. Therefore, in recent years new randomized controlled studies examining effects of vitamin D supplementation on cardiovascular outcomes in children and adolescents have been performed [74][75][76][77][78][79][80][81][82][83][84].…”
Section: The Impact Of Vitamin D Supplementationmentioning
confidence: 99%
“…In the last five years, six RCTs focused on obese nondiabetic adolescents (11-17 years) [79][80][81][82][83][84]. Shah et al [80] failed both to increase 25OHD levels and to alter markers of inflammation and cardiovascular risk in a group of obese adolescents through a vitamin D supplementation of 150,000 IU every 3 months.…”
Section: The Impact Of Vitamin D Supplementationmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, Brar et al [15] used a high dose of VD in obese adolescent and did not find improvement on insulin secretion and sensitivity, and concluded that this supplementation did not appear to produce benefits on the homeostasis of the glucose on obese adolescents. Savastano et al [32] and Gul et al [33] found a negative correlation between VD levels and fasting glycemia.…”
Section: Discussionmentioning
confidence: 98%